Search for correlation of CD8 T cell response to Epstein-Barr virus with clinical status in rheumatoid arthritis: A 15 month followup pilot study

Journal of Rheumatology

Volumn 30, Issue 8, 2003, Pages 1673-1679

  Berthelot, Jean Marie ^a,b   Saulquin, Xavier ^c   Coste Burel, Marianne ^a   Peyrat, Marie A ^c   Echasserieau, Klara ^c   Bonneville, Marc ^c   Houssaint, Elisabeth ^c  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b HÔTEL DIEU   (France)

^c NONE

Author keywords

CD8 T cells; Epstein Barr virus; Lymphocytes; Rheumatoid arthritis

Indexed keywords

CD8 ANTIGEN; ETANERCEPT; GOLD SALT; METHOTREXATE; SALAZOSULFAPYRIDINE; STEROID;

ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; EPSTEIN BARR VIRUS; FATIGUE; FEMALE; HUMAN; HUMAN CELL; HYPOTHESIS; LONGITUDINAL STUDY; LOW DRUG DOSE; MEDICAL ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SYNOVIUM; T LYMPHOCYTE;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CD8-POSITIVE T-LYMPHOCYTES; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPHENOTYPING; LONGITUDINAL STUDIES; MIDDLE AGED; PILOT PROJECTS; POLYMERASE CHAIN REACTION;

EID: 0043031377     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Fox RI, Luppi M, Pisa P, Khang HI. Potential role of Epstein-Barr virus in Sjogren's syndrome and rheumatoid arthritis. J Rheumatol 1992;19 Suppl 32:18-24.
2. Roudier J, Petersen J, Rhodes GH, Luka J, Carson DA. Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110. Proc Natl Acad Sci USA 1989;86:104-8.
3. Toussirot E, Auger I, Roudier C, et al. HLA-DR polymorphism influences T-cell precursor frequencies to Epstein-Barr virus gp110: implications for the association of HLA-DR antigens with rheumatoid arthritis. Tissue Antigens 1999;54:146-52.
4. Herrold RE, Marchini A, Fruehling S, Longnecker R. Glycoprotein 110, the Epstein-Barr virus homolog of herpes simplex virus glycoprotein B, is essential for Epstein-Barr virus replication in vivo. J Virol 1996;70:2049-54.
5. Lee SK, Longnecker R. The Epstein-Barr virus glycoprotein 110 carboxy-terminal tail domain is essential for lytic virus replication. J Virol 1997;71:4092-7.
6. Papworth MA, Van Dijk AA, Benyon GR, Allen TD, Arrand JR, Mackett M. The processing, transport and heterologous expression of Epstein-Barr virus gp110. J Gen Virol 1997;78:2179-89.
7. Houssaint E, Saulquin X, Scotet E, Bonneville M. Immunodominant CD8 T cell response to Epstein-Barr virus. Biomed Pharmacother 2001;55:373-80.
8. Berthelot JM, Bataille R, Maugars Y, Prost A. Rheumatoid arthritis as a bone marrow disorder. Semin Arthritis Rheum 1996;26:505-14.
9. Saal JG, Krimmel M, Steidle M, et al. Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope. Arthritis Rheum 1997;42:1485-96.
10. Koide J, Takada K, Sugiura M, et al. Spontaneous establishment of an Epstein-Barr virus-infected fibroblast line from the synovial tissue of a rheumatoid arthritis patient. J Virol 1997;71:2478-81.
11. Takei M, Mitamura K, Fujiwara S, et al. Detection of Epstein-Barr virus-encoded small RNA 1 and latent membrane protein 1 in synovial lining cells from rheumatoid arthritis patients. Int Immunol 1997;9:739-43.
12. Hiraki A, Fujii N, Masuda K, Ikeda K, Tanimoto M. Genetics of Epstein-Barr virus infection. Biomed Pharmacother 2001;55:369-72.
13. Rooney CM, Roskrow MA, Suzuki N, Ng CY, Brenner MK, Heslop H. Treatment of relapsed Hodgkin's disease using EBV-specific cytotoxic T cells. Ann Oncol 1998;9 Suppl 5:S129-32.
14. Hislop AD, Annels NE, Gudgeon NH, Leese AM, Rickinson AB. Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection. J Exp Med 2002;195:893-905.
15. Babcock GJ, Hochberg D, Thorley-Lawson DA. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 2000;13:497-506.
16. Fazou C, Yang H, McMichael AJ, Callan MFC. Epitope specificity of clonally expanded populations of CD8 T cells found within the joints of patients with inflammatory arthritis. Arthritis Rheum 2001;44:2038-45.
17. David-Ameline J, Lim A, Davodeau F, et al. Selection of T cells reactive against autologous B lymphoblastoid cells during chronic rheumatoid arthritis. J Immunol 1996;157:154-64.
18. Scotet E, David-Ameline J, Peyrat MA, et al. T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis. J Exp Med 1996;184:1791-800.
19. Scotet E, Peyrat MA, Saulquin X, et al. Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions: towards a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes. Eur J Immunol 1999;29:973-85.
20. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
21. Buyse I, Decorte R, Baens M, et al. Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization. Tissue Antigens 1993;41:1-14.
22. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts, Development and validation in prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
23. Saulquin X, Ibisch C, Peyrat MA, et al. A global appraisal of immunodominant CD8 T cell responses to Epstein-Barr virus and cytomegalovirus by bulk screening. Eur J Immunol 2000;30:2531-9.
24. Espevik T, Nissen-Meyer JA. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 1986;95:99-105.
25. Mousavi-Jazi M, Bostrom L, Lovmark C, Linde A, Brytting M, Sundqvist VA. Infrequent detection of cytomegalovirus and Epstein-Barr virus DNA in synovial membrane of patients with rheumatoid arthritis. J Rheumatol 1998;25:623-8.
26. Niedobitek G, Lisner R, Swoboda B, et al. Lack of evidence for an involvement of Epstein-Barr virus infection of synovial membranes in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 2000;43:151-4.
27. Brousset P. Lack of Epstein-Barr virus infection of synovial membranes in patients with rheumatoid arthritis [letter]. Arthritis Rheum 2000;43:2614.
28. Blaschke S, Schwarz G, Moneke D, Binder L, Muller G, Reuss-Borst M. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis. J Rheumatol 2000;27:866-73.
29. Takeda T, Mizugaki Y, Matsubara L, Imai S, Koike T, Takada K. Lytic Epstein-Barr virus infection in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 2000;43:1218-25.
30. Edinger JW, Bonneville M, Scotet E, Houssaint E, Schumacher HR, Posnett DN. EBV gene expression not altered in rheumatoid synovia despite the presence of EBV antigen-specific cell clones. J Immunol 1999;162:3694-701.
31. Bharadwaj M, Burrows SR, Burrows JM, Moss DJ, Catalina M, Khanna R. Longitudinal dynamics of antigen-specific CD8+ cytotoxic T lymphocytes following primary Epstein-Barr virus infection. Blood 2001;98:2588-9.
32. Kalams SA, Walker BD. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte response. J Exp Med 1998;182:2199-204.
33. Zajac AJ, Blattlan JN, Murali-Krishna K, et al. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 1998;188:2205-13.
34. Nikiforow S, Bottomly K, Miller G. CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation. J Virol 2001;75:3740-52.
35. Gross AJ, Thorley-Lawson DA. High numbers of Epstein-Barr virus infected B-lymphocytes in the peripheral blood of patients with systemic lupus erythematosus [abstract]. Arthritis Rheum 2001;44 Suppl:2952.
36. Takei M, Ishiwata T, Milamura K, et al. Decreased expression of signalling lymphocytic-activation molecule-associated protein (SAP) transcripts in T cell from patients with rheumatoid arthritis. Int Immunol 2001;13:559-65.